New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Orexigen Therapeutics, Inc (NASDAQ:OREX), Hovnanian Enterprises, Inc (NYSE:HOV), Ruby Tuesday, Inc (NYSE:RT)
Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed a volume of 3.52million shares by the end of last trade whereas the average volume of the stock remained 2.15 million shares. The stock opened the session at $4.87 but then moved to $4.63. At that price, the stock showed a negative performance of -2.94%. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates. The Company is developing drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors (TLRs). It is also evaluating gene silencing oligonucleotides (GSOs),
Will IDRA Get Buyers Even After The Recent Rally? Find Out Here
Orexigen Therapeutics, Inc (NASDAQ:OREX) opened the session at $6.05 and closed the session at $6.27. The stock showed a positive performance of 4.67% in previous trading session. Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.
For How Long OREX will fight for Profitability? Read This Trend Analysis report
Hovnanian Enterprises, Inc (NYSE:HOV) opened the session at $6.23 and closed the session at $6.20. Traded with volume of 3.47 million shares in the prior session and the average volume of the stock remained 4.63 million shares. The beta of the stock remained 3.26. Hovnanian Enterprises, Inc. (Hovnanian) designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise condominiums, urban infill and active adult homes in planned residential developments. The Company consists of two distinct operations: homebuilding and financial services. Its homebuilding operations consist of six segments: Northeast,including New Jersey and Pennsylvania; Mid-Atlantic, including Delaware,
Is HOV a Solid Investment at These Levels? Read This Report For Details
Ruby Tuesday, Inc (NYSE:RT) the stock advanced 2.85% and finished the session at $6.14. Traded with volume of 3.42 million shares in the prior session and the average volume of the stock remained 671,339 shares. The beta of the stock remained 3.20. Ruby Tuesday, Inc., including its wholly-owned subsidiaries, owns and operates Ruby Tuesday, Lime Fresh Mexican, GrillMarlin & Ray’s, and Wok Hay casual dining restaurants. The Company also operates Truffles restaurants pursuant to a license agreement and franchises the Ruby Tuesday, Lime Fresh, and Wok Hay concepts in selected domestic and international markets.
Will RT Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)